Robust scientific data on when to resume anticoagulation after ICH does not exist.
Does the use of copeptin, either alone or with stratification tools, help identify high-risk patients with pulmonary embolism?
COPD was an independent predictor of in-hospital death and of pulmonary embolism in PAD patients.
Latest News for HOSP
Does a negative computed tomography pulmonary angiography rule out venous thromboembolism (VTE)?
Is venous thromboembolism (VTE) prophylaxis being appropriately prescribed in hospitalized patients?
SAN DIEGO – Results from the PAUSE study could set the standard for timing of perioperative DOAC interruption.
CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds...
A panel of the American Society of Hematology released more than 150 recommendations for dealing with venous thromboembolism.
Researchers suggest rethinking categorization of patients with incident venous thromboembolism.
The agency found the lowest bleeding risk with apixaban, but cites lack of head-to-head trials as a limitation in evaluating DOACs.